We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTD icon
2126
Trade Desk
TTD
$6.49B
$19K ﹤0.01%
+4,210
New +$23.2K
UTI icon
2127
Universal Technical Institute
UTI
$1.59B
$19K ﹤0.01%
7,775
+5,595
+257% +$17.6K
CUTR
2128
DELISTED
Cutera, Inc.
CUTR
$19K ﹤0.01%
410
-747
-65% -$31.5K
DLA
2129
DELISTED
Delta Apparel Inc.
DLA
$19K ﹤0.01%
906
-478
-35% -$9.96K
DSKE
2130
DELISTED
Daseke, Inc. Common Stock
DSKE
$19K ﹤0.01%
1,305
-533
-29% -$7.13K
NM
2131
DELISTED
Navios Maritime Holdings Inc.
NM
$19K ﹤0.01%
1,588
+981
+162% +$15K
FNHC
2132
DELISTED
FedNat Holding Company Common Stock
FNHC
$19K ﹤0.01%
1,148
-1,991
-63% -$29.5K
CALA
2133
DELISTED
Calithera Biosciences, Inc
CALA
$19K ﹤0.01%
113
+104
+1,156% +$26.6K
CONE
2134
DELISTED
CyrusOne Inc Common Stock
CONE
$19K ﹤0.01%
322
+286
+794% +$17.3K
NCOM
2135
DELISTED
National Commerce Corporation
NCOM
$19K ﹤0.01%
465
-2,817
-86% -$117K
NTRI
2136
DELISTED
NutriSystem, Inc.
NTRI
$19K ﹤0.01%
369
-1,966
-84% -$103K
LHO
2137
DELISTED
LaSalle Hotel Properties
LHO
$19K ﹤0.01%
687
-13,161
-95% -$377K
ALOG
2138
DELISTED
Analogic Corp
ALOG
$19K ﹤0.01%
224
-1,515
-87% -$125K
IPXL
2139
DELISTED
Impax Laboratories, Inc.
IPXL
$19K ﹤0.01%
1,128
-3,042
-73% -$55.8K
AVXL icon
2140
Anavex Life Sciences
AVXL
$310M
$18K ﹤0.01%
5,609
-12,259
-69% -$48.2K
CBOE icon
2141
Cboe Global Markets
CBOE
$29.9B
$18K ﹤0.01%
141
-19
-12% -$2.22K
CBT icon
2142
Cabot Corp
CBT
$4.52B
$18K ﹤0.01%
+286
New +$17.2K
CCNE icon
2143
CNB Financial Corp
CCNE
$1.03B
$18K ﹤0.01%
690
-1,089
-61% -$30.4K
CIGI icon
2144
Colliers International
CIGI
$5.19B
$18K ﹤0.01%
233
-2,031
-90% -$117K
CSQ icon
2145
Calamos Strategic Total Return Fund
CSQ
$3.35B
$18K ﹤0.01%
+1,524
New +$18.6K
EEFT icon
2146
Euronet Worldwide
EEFT
$2.7B
$18K ﹤0.01%
+211
New +$19.5K
FFBC icon
2147
First Financial Bancorp
FFBC
$3.53B
$18K ﹤0.01%
683
-5,111
-88% -$138K
FONR
2148
DELISTED
Fonar
FONR
$18K ﹤0.01%
743
-430
-37% -$11.9K
GOGL
2149
DELISTED
Golden Ocean Group
GOGL
$18K ﹤0.01%
2,179
-2,979
-58% -$24.1K
IRBT
2150
DELISTED
iRobot
IRBT
$18K ﹤0.01%
240
-10,309
-98% -$742K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.